NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
52 hedge funds and large institutions have $43.1M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
52
Holding in Top 10
–
Calls
$1.94M
Puts
$1.03M
Top Buyers
| 1 | +$1.17M | |
| 2 | +$867K | |
| 3 | +$606K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$363K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$328K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$517K | |
| 3 | -$480K | |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$245K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$148K |